Please login to the form below

Not currently logged in
Email:
Password:

Flulaval Quadrivalent

This page shows the latest Flulaval Quadrivalent news and features for those working in and with pharma, biotech and healthcare.

China weighs heavy on GSK figures in Q3

China weighs heavy on GSK figures in Q3

Witty emphasised that GSK is entering a new product launch phase with four approvals since the start of the year - including quadrivalent flu vaccine FluLaval and Tyverb (lapatinib) for use alongside

Latest news

  • GSK gets OK for second quadrivalent flu vaccine in US GSK gets OK for second quadrivalent flu vaccine in US

    GSK gets OK for second quadrivalent flu vaccine in US. FDA approves Flulaval Quadrivalent. ... The latest approval is for Flulaval Quadrivalent, which has been given the OK by the FDA for use in patients aged three years or over to protect against A and

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics